NCT03431727

Acromegaly - Before and After Treatment

Sleep Apnea, Circulation and Metabolism in Acromegaly - Before and After Treatment

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 20 (estimated)
• Sponsor: University of Aarhus · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment.

Detailed description

Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma. Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA), which suppresses GH secretion and reduces tumour size, is used when surgery is insufficient or unfeasible. Acromegaly is associated with metabolic abnormalities which contributes to an increased morbidity and mortality if left untreated. To which extend these abnormalities reverses after treatment, and if treatment modality influences the outcome, remain elusive. The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment

Conditions

• Acromegaly
• Growth Hormone Treatment
• Sleep Apnea
• Cardiovascular Diseases
• Bone Diseases

Timeline

• Start date: 2017-10-01
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2018-02-13
• Last updated: 2020-12-07

Locations

1 site across 1 country: Denmark